Discovery Platform
From Target to Market

Discovery Services

Proven Chemistry

Screening Libraries
1.6M Compounds eShop

Pharmaceutical
Development

Pharmaceutical Development

Why Choose ChemDiv?

  • 25 years experience and 2500 customers worldwide
  • Premium R&D CRO based in USA with global reach
  • Seasoned project managers
  • Extensive Academic partnerships
  • Flexible business models
  • Industry's largest ever-greening stock compound inventory
  • Ongoing investments in novel proprietary chemistry and discovery platforms
Learn More About Us

Our News

“First Principle” Concept in Designing Small Molecules for Targeting RNA Expansion Repeats
ChemDiv Posters At “EFMC-ASMC’19”: Macrocyclic Peptidomimetics And Library of Covalent Inhibitors
Macrocyclic Peptidomimetics: Library Design And Synthesis
Read All Our News >

Pharma News

FDA Approves Entrectinib Based on Tumor Genetics Rather Than Cancer Type
U.S. records no new measles cases for first week since January
First peanut allergy therapy gets backing from U.S. regulators’ expert advisers
Read All Pharma News >

New Products &Services

Target Activity profiling library
MCE-18 Trends in MedChem
Covalent Inhibitors library
RNA Trinucleotide mimetics
Share this: